FDA Brief

Warning letters Food

FDA warning letter to

1am USA Incorporated dba Pleasure Products USA

High riskIssued Jul 1, 2022Posted Jul 12, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA found undeclared tadalafil, the active ingredient in Cialis, in 1am USA's X RATED HONEY FOR MEN sold online.

What happened

FDA bought samples of X RATED HONEY FOR MEN directly from www.pleasureproductsusa.com and reviewed the website in June 2022. Laboratory analysis found undeclared tadalafil, the active ingredient in the prescription drug Cialis. The website marketed the honey as a dietary supplement and showed a "Supplement Facts" label.

What FDA found

  1. The honey contains undeclared tadalafil, a prescription drug ingredient, so selling it as a food with an added approved drug is a prohibited act.

    FD&C Act section 301(ll) [21 U.S.C. 331(ll)]
  2. The product is marketed as a dietary supplement, but it cannot be one because tadalafil is an approved drug ingredient and is excluded from the dietary supplement definition.

    FD&C Act sections 201(ff)(3)(B)(i) and (ii) [21 U.S.C. 321(ff)(3)(B)(i) and (ii)]
  3. The undeclared tadalafil may interact with nitrates in some prescription drugs and lower blood pressure to dangerous levels.

What FDA wants

FDA tells the company to notify it in writing within 15 working days of the specific steps taken to address the violations and prevent recurrence, with related documentation. If corrective actions cannot be completed in that time, the company must state why and when it will finish.

Who should pay attention

  • online retailers selling honey-based male enhancement products
  • consumers who take nitrate drugs such as nitroglycerin
  • firms marketing products as dietary supplements with Supplement Facts labels

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  2. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk